Sandra Lee and Amy Robach Co-Host NYC Event
New York, New York, January 16, 2019 -- WebMD celebrated the accomplishments and contributions of researchers, health care professionals and advocates who are helping to transform the impact of cancer during its Health Heroes event in New York City yesterday.
Advocate, filmmaker, and cancer survivor Sandra Lee and 20/20 co-anchor, ABC News correspondent, and cancer survivor Amy Robach kicked off the event following opening remarks from WebMD CEO Bob Brisco.
Robach noted that this year’s Health Heroes are “…changing the world. They are transforming the way we think about prevention, making breakthrough discoveries, raising money and awareness and so much more.”
“These winners each saw a need and used their own unique gifts to serve that need. They embody selflessness and tenacity and talent,” said Lee.
On hand to present the awards were Stand Up To Cancer President and CEO Sung Poblete, PhD, RN; journalist and author Joan Lunden; Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, William Nelson, MD, PhD; CEO of the American Society of Clinical Oncologists, Clifford Hudis MD; SU2C researcher Padmanee Sharma MD, PhD, and cancer patient Judy Ochs.
For a recap and to learn more about the winners of the 2019 WebMD Health Hero Awards visit www.webmd.com/healthheroes.
The WebMD Health Heroes are:
Kathy Bates, actor, cancer survivor and active spokesperson for the Lymphatic Education & Research Network
Academy Award winner, Tony nominee, and Emmy Award-winning actor and director Kathy Bates is an ovarian and breast cancer survivor who also developed lymphedema, a buildup of fluid in soft tissue, following surgery for a double mastectomy. She is a national spokesperson for the Lymphatic Education & Research Network (LE&RN), which funds research into lymphedema and lymphatic diseases, provides scholarships for lymphedema therapists, sponsors an international patient registry, and provides patient education.
Earlier this year, she sponsored a LE&RN walk in New York City to raise awareness of the condition and help reduce stigma. She also led advocates in a Capitol Hill Lobby Day to petition for congressional support for lymphedema research funding, followed by another walk in Washington, D.C., to raise awareness. Ms. Bates has received a Women Making History Award by the National Women’s History Museum, an organization focused on building a Women’s Museum on the National Mall in Washington.
Ms. Bates is also a Stand Up To Cancer Ambassador and a longtime supporter of SU2C, having participated in many of their initiatives and televised events.
James P. Allison, PhD, 2018 Nobel laureate and pioneer in cancer immunotherapy
Dr. James Allison, chair of the Department of Immunology at MD Anderson Cancer Center, has spent his career studying the regulation of T-cell responses and developing strategies for cancer immunotherapy. His discoveries led him to pioneer immune checkpoint blockade as a cancer treatment. Earlier this year, he was awarded, along with co-recipient Tasuku Honjo, the 2018 Nobel Prize for his breakthrough discovery that blocks a mechanism that enables cancer cells to evade the body’s immune system. Hailed by the Nobel committee as a landmark in the fight against cancer, the discovery is being recognized as revolutionizing cancer treatment and fundamentally changing how cancer can be managed.
Dr. Allison continues to conduct basic research as well as translational studies of immunotherapies and combination therapies to uncover factors that influence response and resistance to checkpoint blockades, including as Leader of the SU2C-CRI Immunology Dream Team. His mother and two uncles died of cancer.
Rufus Wainwright, singer, composer and Stand Up To Cancer Ambassador
Rufus Wainwright is a Grammy-nominated singer, songwriter, composer, and Ambassador for the Stand Up To Cancer Kate McGarrigle Fund. His latest opera, Hadrian, recently premiered in Toronto. His mother, the folk singer Kate McGarrigle, was diagnosed with a rare form of sarcoma in 2006 and died in 2010. Mr. Wainwright and his sister, Martha, founded the Kate McGarrigle Foundation in 2016 to raise money in the fight against sarcoma, the rare and underfunded cancer that took his mother's life. Sing Me the Songs That Say I Love You: A Concert for Kate McGarrigle is a documentary film that captures the highlights of a 2011 tribute concert in New York City. In 2018, the Kate McGarrigle Foundation joined forces with Stand Up To Cancer, forming the SU2C Kate McGarrigle Fund, a new collaborative program to provide music therapy resources to cancer patients with a passion for music, as well as much needed funds for sarcoma research.
Karen M. Winkfield, MD, PhD, thought leader on racial disparities in cancer outcomes
Dr. Karen M. Winkfield is a radiation oncologist and director of the Office of Cancer Health Equity at Wake Forest Baptist Comprehensive Cancer Center. She is past chair of the American Society of Clinical Oncology Health Disparities Committee, and she focuses her research on understanding and addressing sociocultural barriers that contribute to disparities in cancer outcomes. The goal of her research is to develop platforms for discussion that enable accurate and timely dispersal of health information to improve health literacy among underserved communities and encourage policymakers to invest in initiatives designed to address inequalities in the health care delivery system. Dr. Winkfield is also co-founder and director of the Association of Black Radiation Oncologists.
Elizabeth "Liz" Marion Jaffee, MD, researcher who uses novel vaccines to overcome immune tolerance
Dr. Elizabeth "Liz" Marion Jaffee is associate director at Bloomberg-Kimmel Institute for Cancer Immunotherapy and deputy director of The Johns Hopkins Kimmel Cancer Center. She is an international leader in the development of immune-based therapies for pancreatic and breast cancers. She holds six vaccine patents. Her research is focused on developing new vaccines that overcome immune tolerance to cancers and slowing the rate at which the disease spreads to other organs. Dr. Jaffee is the Leader of the SU2C-Lustgarten Foundation Pancreatic Cancer Dream Team.
Lillie Shockney, RN, MAS, one of the leading cancer nurses in the U.S.
Lillie Shockney is administrative director of the Johns Hopkins Breast Center and the director of Johns Hopkins Cancer Survivorship Programs. She is a two-time breast cancer survivor, oncology registered nurse, and nurse navigator. She is nationally and internationally known for her work in patient advocacy and a multidisciplinary approach to patient-centered oncology care, emphasizing the importance of beginning survivorship care at the moment of diagnosis. Professor Shockney is the co-founder and program director of the Academy of Oncology Nurse and Patient Navigators, and is the co-developer of Johns Hopkins Medicine’s Work Stride Managing Cancer at Work, an employee benefit for businesses and corporations nationally. She is also co-founder and vice president of a national nonprofit organization called Mothers Supporting Daughters with Breast Cancer, which has served tens of thousands of families nationally and internationally since its founding in 1995. Professor Shockney served as Patient Advocate on the inaugural SU2C Epigenetics Dream Team.
Margaret I. Cuomo, MD, radiologist, author, and cancer prevention advocate
Dr. Margaret I. Cuomo is a board-certified radiologist, philanthropist, advocate, and author on health and medicine, focused on topics related to cancer prevention. She is the author of A World Without Cancer: The Making of a New Cure and the Real Promise of Prevention (2012), where she explores needed improvements in screening, diagnosis, patient education, and coordination among governments, academic researchers, and pharmaceutical companies. In 2016, PBS aired her one-hour documentary version of A World Without Cancer, featuring documentarian Ken Burns and singer/songwriter Valerie Simpson.
Dr. Cuomo sits on the leadership council for True Health Initiative, a global movement focused on a healthy "lifestyle as medicine." In 2018, she joined the board of HeritX.org, a global research and development organization that focuses on the prevention of BRCA-related and other inherited cancers. Until 2017, she served as a board member of, and she led Capitol Hill conferences for, LessCancer.org, focusing on cancer risk reduction and prevention.
"This year’s Health Hero awards recipients are a diverse and inspiring group of individuals that share a powerful commitment to improving the lives of people who are living with cancer, cancer survivors, and the people who love them,” said Kristy Hammam, editor in chief and senior vice president of WebMD. “We are proud to honor their work to meet the complex challenges of cancer both clinically and societally and in the day-to-day of people’s lives.”
WebMD has made a contribution to Stand Up To Cancer on behalf of the award recipients, and the winners will be featured in a special edition of the March/April 2019 issue of WebMD Magazine.
To read more about WebMD’s Health Heroes or to learn more about the awards, please visit www.webmd.com/healthheroes.
Additional images available upon request
WebMD Health Corp., an Internet Brands Company, is the leading provider of health information services, serving patients, physicians, health care professionals, employers, and health plans through public and private online portals, mobile platforms, and health-focused publications. The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites.
WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org®, and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.
About Internet Brands
Headquartered in El Segundo, Calif., Internet Brands® is a fully integrated online media and software services organization focused on four high-value vertical categories: Health, Automotive, Legal, and Home/Travel. The company's award-winning consumer websites lead their categories and serve more than 250 million monthly visitors, while a full range of web presence offerings has established deep, long-term relationships with SMB and enterprise clients. Internet Brands' powerful, proprietary operating platform provides the flexibility and scalability to fuel the company's continued growth. Internet Brands is a portfolio company of KKR and Temasek. For more information, please visit www.internetbrands.com.